Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of human pancreatic cancer cell tumorigenicity by alpha1,3galactosyltransferase gene transfer.

Muriel Aubert1, Christian Crotte, Jean-Paul Bernard

  • 1Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 559 and Université de la Méditerranée EA 3289, Faculté de Médecine, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France.

International Journal of Cancer
|November 6, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Common single-base insertions in the VNTR of the carboxyl ester lipase (CEL) gene are benign and also likely to arise somatically in the exocrine pancreas.

Human molecular genetics·2024
Same author

Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels: A study based on therapeutic drug monitoring data.

British journal of clinical pharmacology·2023
Same author

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis.

EBioMedicine·2021
Same author

Surface Charge of Supramolecular Nanosystems for In Vivo Biodistribution: A MicroSPECT/CT Imaging Study.

Small (Weinheim an der Bergstrasse, Germany)·2020
Same author

Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma.

Frontiers in immunology·2020
Same author

A self-assembling amphiphilic dendrimer nanotracer for SPECT imaging.

Chemical communications (Cambridge, England)·2019

Introducing alphaGal epitopes onto human pancreatic cancer cells using alpha1,3galactosyltransferase gene transfer reduced tumor growth and metastasis in mice. This modification also activated the immune system, showing potential for cancer therapy.

Area of Science:

  • Immunology
  • Glycobiology
  • Oncology

Background:

  • The alphaGal epitope (Galalpha1,3Galbeta1,4GlcNAc-R) is synthesized by alpha1,3galactosyltransferase in lower mammals but absent in humans.
  • Human serum contains natural anti-alphaGal antibodies, potentially involved in host defense and xenograft rejection.
  • Glycosyltransferase gene transfer can alter cell surface glycoconjugates, influencing tumor behavior.

Purpose of the Study:

  • To investigate if expressing alphaGal epitopes modifies the tumorigenicity of human pancreatic cancer cells.
  • To assess the impact of alphaGal epitope expression on immune response and tumor development in vivo.

Main Methods:

  • Transfection of human pancreatic cancer cell lines (BxPC-3, Panc-1) with the murine alpha1,3galactosyltransferase gene.

Related Experiment Videos

  • Confirmation of alphaGal epitope expression and recognition by human anti-alphaGal antibodies.
  • Evaluation of complement fixation and in vivo tumor development after xenograft transplantation in nude mice.

    • Main Results:

    • Stable expression of alphaGal epitopes was achieved on BxPC-3 and Panc-1 cells.
    • Expressed alphaGal epitopes were recognized by human anti-alphaGal antibodies, leading to complement 1q fixation.
    • Xenografted pancreatic cancer cells expressing alphaGal epitopes showed delayed tumor development in nude mice.

    Conclusions:

    • Cell surface expression of alphaGal epitopes modulates the tumorigenic behavior of human pancreatic cancer cells.
    • AlphaGal epitope expression can impair metastatic potential and activate an immune response.
    • This strategy offers a potential approach for modifying pancreatic cancer cell behavior and enhancing anti-tumor immunity.